Literature DB >> 536420

Simple gas-liquid chromatographic method for the measurement of mexiletine and lignocaine in blood-plasma or serum.

D W Holt, R J Flanagan, A M Hayler, M Loizou.   

Abstract

A simple method has been developed for the measurement of mexiletine and lignocaine in blood-plasma or serum at the concentrations attained during therapy. A relatively small (200 microliter) sample volume is made basic and extracted with 50 microliter of chloroform containing internal standards, and the extract is analysed directly by gas-liquid chromatography with flame-ionisation detection on two separate columns. The instrument calibrations are linear and pass through the origin of the graphs. Neither solvent transfer nor evaporation steps are used in the extraction procedure, which takes less than 3 min to complete, and no interference from either endogenous sample constituents or other drugs has been observed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 536420     DOI: 10.1016/0021-9673(75)85053-9

Source DB:  PubMed          Journal:  J Chromatogr


  6 in total

1.  A trial of prophylactic mexiletine in home coronary care.

Authors:  J A Bell; J M Thomas; J R Isaacson; N J Snell; D W Holt
Journal:  Br Heart J       Date:  1982-09

2.  Effect of rifampicin treatment on the kinetics of mexiletine.

Authors:  P J Pentikäinen; I H Koivula; H A Hiltunen
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of the newer antiarrhythmic agents.

Authors:  A M Gillis; R E Kates
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

4.  Pharmacokinetics of oral mexiletine in patients with acute myocardial infarction.

Authors:  P J Pentikäinen; M O Halinen; M J Helin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Plasma concentrations of lignocaine during fibreoptic bronchoscopy.

Authors:  J Efthimiou; T Higenbottam; D Holt; G M Cochrane
Journal:  Thorax       Date:  1982-01       Impact factor: 9.139

6.  Cirrhosis of the liver markedly impairs the elimination of mexiletine.

Authors:  P J Pentikäinen; S Hietakorpi; M O Halinen; L M Lampinen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.